Sandoz concludes acquisition of Mycamine antifungal agent from Astellas
Novartis division Sandoz has concluded the acquisition of global brand rights for the antifungal agent Mycamine from Astellas.
Novartis division Sandoz has concluded the acquisition of global brand rights for the antifungal agent Mycamine from Astellas.
What's Your Reaction?
